Authors:
Roob, JM
Rabold, T
Hayn, M
Khoschsorur, G
Resch, U
Holzer, H
Winklhofer-Roob, BM
Citation: Jm. Roob et al., Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD, KIDNEY INT, 59, 2001, pp. S128-S136
Authors:
Pollak, A
Hayde, M
Hayn, M
Herkner, K
Lombard, KA
Lubec, G
Weninger, M
Widness, JA
Citation: A. Pollak et al., Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants, PEDIATRICS, 107(1), 2001, pp. 78-85
Authors:
Zarkovic, N
Hayn, M
Tatzber, F
Reichel, H
Korsic, M
Zarkovic, K
Plavsic, V
Breskovac, L
Klingmuller, M
Paladino, J
Citation: N. Zarkovic et al., Growth promoting effect of human plasma ultrafiltrate bioactive fraction (TBP) for human non-functioning pituitary adenoma cells in vitro, J ENDOC INV, 23(11), 2000, pp. 737-743
Authors:
Meraji, S
Abuja, PM
Hayn, M
Kostner, GM
Morris, R
Oraii, S
Tatzber, F
Wonisch, W
Zechner, R
Gey, KF
Citation: S. Meraji et al., Relationship between classic risk factors, plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran, ATHEROSCLER, 150(2), 2000, pp. 403-412
Authors:
Page, S
Fischer, C
Baumgartner, B
Haas, M
Kreusel, U
Loidl, G
Hayn, M
Ziegler-Heitbrock, HWL
Neumeier, D
Brand, K
Citation: S. Page et al., 4-hydroxynonenal prevents NF-kappa B activation and tumor necrosis factor expression by inhibiting I kappa B phosphorylation and subsequent proteolysis, J BIOL CHEM, 274(17), 1999, pp. 11611-11618